title: PISCES: a horoscope for first-line targeted therapy of metastatic renal cell carcinoma.
authors.affiliation: University of Montreal Health Center, Montreal, Quebec, Canada mcw.sun@umontreal.ca.
authors.forename: Maxine
authors.initials: M
authors.lastname: Sun
authors.affiliation: University of Montreal Health Center, Montreal, Quebec, Canada.
authors.forename: Alessandro
authors.initials: A
authors.lastname: Larcher
authors.affiliation: University of Montreal Health Center, Montreal, Quebec, Canada.
authors.forename: Jonas
authors.initials: J
authors.lastname: Schiffmann
authors.affiliation: University of Montreal Health Center, Montreal, Quebec, Canada.
authors.forename: Pierre I
authors.initials: PI
authors.lastname: Karakiewicz
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D057240:Patient Preference; D011743:Pyrimidines / Q000009:adverse effects*; D011758:Pyrroles / Q000009:adverse effects*; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D007211:Indoles; D011743:Pyrimidines; D011758:Pyrroles; D013449:Sulfonamides